"Psilocybin Behavioral Health Access and Services Act"; authorizes production and use of psilocybin to promote health and wellness.

This bill, now law as P.L.2025, c.296, establishes a regulated system for psilocybin use in New Jersey to treat behavioral health conditions. It authorizes licensed psilocybin service centers to provide supervised sessions for adults 21+ with conditions like depression or anxiety, requiring trained facilitators and mandatory follow-up therapy sessions. The law creates licensing requirements for service centers, manufacturers, and facilitators, and mandates a state advisory board to oversee implementation. It directly affects New Jersey residents aged 21+ with behavioral health needs seeking this treatment option, while prohibiting access for minors and preventing illegal diversion.